IR-1061 Near Infrared Fluorescent Dye: Deep Tissue Imaging Empowered

Principle and Setup: Why IR-1061 Stands Out for In Vivo Imaging

Near-infrared (NIR) fluorescence imaging has emerged as a cornerstone technology in biomedical research due to its ability to penetrate tissue deeply with minimal phototoxicity and background interference. The recently highlighted IR-1061 dye exemplifies this innovation, emitting in the critical over-1000 nm (OTN-NIR or NIR-II) window. This region—spanning 1000–1350 nm—offers superior tissue penetration and signal clarity compared to traditional dyes that operate in the UV-visible or NIR-I windows. According to the reference study, IR-1061’s unique optical properties enable high-resolution detection of internal structures and pathologies, facilitating advanced molecular imaging workflows previously hampered by shallow penetration or high background noise.

IR-1061 features a solid-state, thermally stable profile (C44H34BClF4S2, MW 749.13) and is highly soluble in DMSO at concentrations ≥25.65 mg/mL, while remaining insoluble in ethanol and water. This solubility profile is crucial for designing robust aqueous imaging systems, particularly when used in conjunction with biocompatible polymers that facilitate dye encapsulation and delivery.

Protocol Parameters

• Dye Dissolution: Dissolve IR-1061 at 25.65 mg/mL or higher in DMSO at room temperature; avoid ethanol or water as solvents due to insolubility.
• Polymer Nanoparticle Formation: Mix IR-1061-loaded DMSO solution with a PEG-b-PCL copolymer (5 mg/mL) and rapidly inject into 10 mL of deionized water under vigorous stirring to induce micelle self-assembly. Incubate for 1 hour at room temperature.
• In Vivo Injection: For mouse models, administer the IR-1061-loaded nanoparticle suspension intravenously at 100–200 μL per 20–25 g animal; image within 1–4 hours post-injection for optimal signal.

Step-by-Step Workflow: Enhanced Experimental Design for IR-1061

Deploying IR-1061 for fluorescence imaging requires thoughtful integration of its physicochemical profile with state-of-the-art nanoparticle delivery systems. Here is a streamlined, literature-backed workflow:

1. Preparation of Fresh Stock: Weigh the desired amount of IR-1061 and dissolve directly in DMSO at concentrations ≥25.65 mg/mL, ensuring the solution is freshly prepared before each experiment to maintain maximal fluorescence intensity, as long-term storage leads to signal degradation (product information).
2. Encapsulation in PEG-b-PCL Micelles: Following the reference study, combine the IR-1061/DMSO solution with a PEG-b-PCL copolymer. Rapidly inject this mix into deionized water under stirring to facilitate micelle formation, trapping the hydrophobic dye in the core and rendering it dispersible in aqueous environments.
3. Purification: Remove free dye and DMSO by dialysis or ultrafiltration against PBS, ensuring that only nanoparticle-encapsulated IR-1061 remains. This step is critical for minimizing background and toxicity in in vivo applications.
4. Imaging: Administer the nanoparticle suspension intravenously or by the preferred route. Image animals using an NIR-II compatible imaging system (excitation 980–1064 nm, emission >1000 nm) within the optimal post-injection window (typically 1–4 hours) to capture peak signal at the target site.

These steps address the dye's low aqueous solubility and maximize signal by leveraging the self-assembly properties of PEG-b-PCL, as detailed in the reference study.

Key Innovation from the Reference Study

The landmark advancement described in the reference study is the simple, one-pot encapsulation of IR-1061 into biodegradable PEG-b-PCL polymer micelles. This innovation bypasses the multi-step synthesis and high technical barriers associated with traditional inorganic OTN-NIR nanomaterials (e.g., quantum dots or rare-earth nanoparticles), enabling any molecular imaging lab to prepare stable, body-circulating NIR-II probes in under two hours.

• This approach allows precise control over nanoparticle size (10–100 nm), optimizing blood circulation half-life and tumor targeting via the enhanced permeability and retention (EPR) effect.
• Biodegradability of PEG-b-PCL ensures renal clearance post-imaging, reducing long-term safety concerns for translational research.
• Both the dye and polymer are commercially available, democratizing access to OTN-NIR imaging capability without specialized nanochemistry expertise.

For assay design, this means rapid, reproducible preparation of NIR-II fluorescent nanoparticles suitable for high-sensitivity vascular, tumor, and organ imaging in small animal models, with minimal background interference and strong translational relevance.

Advanced Applications and Comparative Advantages

IR-1061’s core advantage as a near infrared fluorescent dye lies in its emission profile (NIR-II window), which allows for imaging depths and resolution unattainable with most visible or NIR-I dyes. When compared to traditional fluorophores or even advanced quantum dots, IR-1061-loaded nanoparticles offer:

• Superior Tissue Penetration: Signals can be detected several centimeters deep within tissue, vastly outperforming visible and NIR-I probes—crucial for vascular, lymphatic, and tumor imaging (related article).
• Minimal Autofluorescence: The NIR-II region is nearly free from endogenous tissue autofluorescence, resulting in higher contrast and reduced background.
• Fast Clearance and Biocompatibility: The use of biodegradable polymers for encapsulation ensures that the imaging agent is efficiently cleared after experiments, addressing safety and regulatory concerns for translational studies.

This approach is particularly beneficial for researchers seeking a fluorescent dye for in vivo imaging that is both high-performing and practical for routine biomedical studies. The workflow outlined here complements findings from "Advancing Translational Imaging from Mechanism to Medicine", which highlights how IR-1061’s unique properties enable researchers to bridge the gap between mechanistic discoveries and clinical model validation.

Troubleshooting and Optimization Tips

Despite IR-1061’s robust performance, several common issues may arise during experimental workflows. Below are actionable troubleshooting strategies:

• Poor Aqueous Solubility: Always encapsulate IR-1061 in a hydrophobic core of a block copolymer micelle such as PEG-b-PCL. Avoid direct dilution into aqueous buffers, as this leads to aggregation and signal loss.
• Signal Degradation on Storage: Prepare IR-1061 solutions and nanoparticles fresh for each experiment. Long-term storage, even at -20°C, can reduce fluorescence intensity due to gradual dye degradation (product info).
• Low Imaging Contrast: Confirm removal of free dye through thorough dialysis or repeated ultrafiltration. Residual free dye increases non-specific background.
• Batch-to-Batch Variability: Standardize polymer and dye concentrations, mixing times, and water injection rates. Use HPLC and NMR analyses for quality control when possible, as recommended by APExBIO.
• Imaging System Compatibility: Ensure that your imaging system is optimized for NIR-II detection (excitation near 1064 nm, emission filters >1000 nm). Suboptimal detection windows may underestimate true probe performance.

For more troubleshooting guidance, this practical guide offers additional workflow tips, including comparative analyses with other NIR dyes.

Outlook: Where IR-1061 is Taking Biomedical Imaging

The integration of IR-1061 with advanced polymer encapsulation is already reshaping the frontiers of fluorescent dye for molecular imaging. As evidenced by the reference study and complementary literature, the simplicity, reproducibility, and biocompatibility of this approach are enabling broader adoption of deep tissue imaging for preclinical models. The next steps will likely include:

• Refinement of polymer–dye systems to further optimize quantum yield and circulation time, as discussed in this article on polymer chirality.
• Expansion into multiplexed imaging, leveraging the NIR-II window to visualize multiple biological targets simultaneously without spectral overlap.
• Facilitating translational studies by reducing preparation barriers and enabling safe, high-resolution imaging in larger animal models.

With APExBIO’s rigorous quality controls and accessible supply of IR-1061, researchers are now equipped to pursue next-generation imaging studies with confidence—pushing the boundaries of what’s visible beneath the surface.